Santhera Pharmaceuticals Holding AG

Research Santhera Pharmaceuticals Holding AG (SANN) on Bullrun: market cap CHF 235.82M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSANN
• ExchangeSW
• CountrySwitzerland
• SectorHealthcare
• IndustryBiotechnology
• CurrencyCHF
• Market capCHF 235.82M
• Financial periodFY2024
• RevenueCHF 39.12M
• Revenue growth-62.2%
• Net income-CHF 41.97M
• Free cash flow-CHF 35.68M
• Gross margin60.3%

Valuation Snapshot

latest market cap is CHF 235.82M.

About Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.

Frequently asked questions

What is Santhera Pharmaceuticals Holding AG's market cap?

Santhera Pharmaceuticals Holding AG's market capitalization is CHF 235.82M.

What does Santhera Pharmaceuticals Holding AG do?

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.